Found: 9
Select item for more details and to access through your institution.
Evolution of the predictive markers amphiregulin and epiregulin mRNAs during long-term cetuximab treatment of KRAS wild-type tumor cells.
- Published in:
- Investigational New Drugs, 2012, v. 30, n. 2, p. 846, doi. 10.1007/s10637-010-9612-2
- By:
- Publication type:
- Article
Stem cell property epithelial-to-mesenchymal transition is a core transcriptional network for predicting cetuximab (Erbitux™) efficacy in KRAS wild-type tumor cells.
- Published in:
- Journal of Cellular Biochemistry, 2011, v. 112, n. 1, p. 10, doi. 10.1002/jcb.22952
- By:
- Publication type:
- Article
Oxaliplatin in Combination With Infusional 5-Fluorouracil as First-Line Chemotherapy for Elderly Patients With Metastatic Colorectal Cancer: A Phase II Study of the Spanish Cooperative Group for the Treatment of Digestive Tumors.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
Capecitabine and irinotecan with bevacizumab 2-weekly for metastatic colorectal cancer: the phase II AVAXIRI study.
- Published in:
- BMC Cancer, 2015, v. 15, n. 1, p. 1, doi. 10.1186/s12885-015-1293-y
- By:
- Publication type:
- Article
Capecitabine and irinotecan with bevacizumab 2-weekly for metastatic colorectal cancer: the phase II AVAXIRI study.
- Published in:
- 2015
- By:
- Publication type:
- journal article
EphA2 receptor activation with ephrin-A1 ligand restores cetuximab efficacy in NRAS-mutant colorectal cancer cells.
- Published in:
- Oncology Reports, 2017, v. 38, n. 1, p. 263, doi. 10.3892/or.2017.5682
- By:
- Publication type:
- Article
Correction to: A Phase II Study Evaluating Combined Neoadjuvant Cetuximab and Chemotherapy Followed by Chemoradiotherapy and Concomitant Cetuximab in Locoregional Oesophageal Cancer Patients.
- Published in:
- 2018
- By:
- Publication type:
- journal article
A phase II Study Evaluating Combined Neoadjuvant Cetuximab and Chemotherapy Followed by Chemoradiotherapy and Concomitant Cetuximab in Locoregional Oesophageal Cancer Patients.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Phase II study of trastuzumab and cisplatin as first-line therapy in patients with HER2-positive advanced gastric or gastroesophageal junction cancer.
- Published in:
- Clinical & Translational Oncology, 2011, v. 13, n. 3, p. 179, doi. 10.1007/s12094-011-0637-6
- By:
- Publication type:
- Article